[{"address1": "150 West 4th Ave", "city": "Vancouver", "state": "BC", "zip": "V5Y 1G6", "country": "Canada", "phone": "604 559 9005", "website": "https://www.abcellera.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.", "fullTimeEmployees": 596, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl L.G. Hansen Ph.D.", "age": 51, "title": "CEO, President & Chairperson", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 746836, "exercisedValue": 210706, "unexercisedValue": 2408685}, {"maxAge": 1, "name": "Mr. Andrew  Booth M.B.A.", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 671720, "exercisedValue": 0, "unexercisedValue": 12299500}, {"maxAge": 1, "name": "Dr. Veronique  Lecault Ph.D.", "age": 41, "title": "CTO & Director", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 667706, "exercisedValue": 230210, "unexercisedValue": 1260000}, {"maxAge": 1, "name": "Mr. Tryn T. Stimart Esq., J.D., M.Sc.", "age": 56, "title": "Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 685080, "exercisedValue": 0, "unexercisedValue": 3502170}, {"maxAge": 1, "name": "Mr. Andrew  Knowles M.Sc.", "title": "VP of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Marcie  Thiessen CPA, CGA", "title": "Senior Director of Finance & Accounting", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tiffany  Chiu B.Sc., Ph.D.", "title": "Vice President of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Graham  Craig M.Sc.", "title": "Director of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Caitlin  Webster CIPD, M.Sc.", "title": "Director of Talent Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Murray  McCutcheon Ph.D.", "title": "Senior Vice President of Partnering", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 8, "governanceEpochDate": 1767225600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.11, "open": 4.19, "dayLow": 4.19, "dayHigh": 4.505, "regularMarketPreviousClose": 4.11, "regularMarketOpen": 4.19, "regularMarketDayLow": 4.19, "regularMarketDayHigh": 4.505, "payoutRatio": 0.0, "beta": 0.734, "forwardPE": -6.333333, "volume": 6385199, "regularMarketVolume": 6385199, "averageVolume": 4280200, "averageVolume10days": 4253440, "averageDailyVolume10Day": 4253440, "bid": 2.56, "ask": 4.26, "bidSize": 2, "askSize": 2, "marketCap": 1308094080, "fiftyTwoWeekLow": 1.891, "fiftyTwoWeekHigh": 6.515, "allTimeHigh": 71.91, "allTimeLow": 1.891, "priceToSalesTrailing12Months": 37.030266, "fiftyDayAverage": 3.8944, "twoHundredDayAverage": 3.7645, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 954640128, "profitMargins": 0.0, "floatShares": 204326104, "sharesOutstanding": 299335048, "sharesShort": 50505133, "sharesShortPriorMonth": 54443811, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.16870001, "heldPercentInsiders": 0.22969, "heldPercentInstitutions": 0.36965, "shortRatio": 13.61, "shortPercentOfFloat": 0.2188, "impliedSharesOutstanding": 299335048, "bookValue": 3.224, "priceToBook": 1.355459, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -171676992, "trailingEps": -0.57, "forwardEps": -0.69, "enterpriseToRevenue": 27.024, "enterpriseToEbitda": -4.103, "52WeekChange": 0.37, "SandP52WeekChange": 0.18594909, "quoteType": "EQUITY", "currentPrice": 4.37, "targetHighPrice": 16.0, "targetLowPrice": 7.0, "targetMeanPrice": 9.83333, "targetMedianPrice": 9.5, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 495672000, "totalCashPerShare": 1.656, "ebitda": -232664000, "totalDebt": 142218000, "quickRatio": 8.485, "currentRatio": 10.103, "totalRevenue": 35325000, "debtToEquity": 14.752, "revenuePerShare": 0.119, "returnOnAssets": -0.10426, "returnOnEquity": -0.16814, "grossProfits": -147487008, "freeCashflow": -241470496, "operatingCashflow": -104552000, "revenueGrowth": 0.376, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -8.51792, "financialCurrency": "USD", "symbol": "ABCL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607697000000, "postMarketChangePercent": 3.890162, "postMarketPrice": 4.54, "postMarketChange": 0.17000008, "regularMarketChange": 0.26, "regularMarketDayRange": "4.19 - 4.505", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 4280200, "fiftyTwoWeekLowChange": 2.4789999, "fiftyTwoWeekLowChangePercent": 1.3109465, "fiftyTwoWeekRange": "1.891 - 6.515", "fiftyTwoWeekHighChange": -2.145, "fiftyTwoWeekHighChangePercent": -0.32924023, "fiftyTwoWeekChangePercent": 37.0, "earningsTimestamp": 1762462800, "earningsTimestampStart": 1762462800, "regularMarketChangePercent": 6.32603, "regularMarketPrice": 4.37, "corporateActions": [], "postMarketTime": 1768006677, "regularMarketTime": 1767992401, "exchange": "NMS", "messageBoardId": "finmb_280568380", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "AbCellera Biologics Inc.", "longName": "AbCellera Biologics Inc.", "earningsTimestampEnd": 1762462800, "earningsCallTimestampStart": 1762466400, "earningsCallTimestampEnd": 1762466400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.57, "epsForward": -0.69, "epsCurrentYear": -0.6525, "priceEpsCurrentYear": -6.697318, "fiftyDayAverageChange": 0.4756, "fiftyDayAverageChangePercent": 0.12212408, "twoHundredDayAverageChange": 0.6055, "twoHundredDayAverageChangePercent": 0.16084473, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-12-11", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "AbCellera Biologics", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]